Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)
Clinical trial NCT06136897 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06136897
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-23
- Primary completion
- 2021-11-03
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.